Santa Barbara, CA-Mentor Corp. offers a new ergonomically designed Self-Cath Closed System for the management of urinary retention. A sterile, unisex device for individuals who must maintain an intermittent self-catheterization schedule, the system includes a pre-lubricated 100% latex-free intermittent catheter and a new, narrow collection bag.
Vobramitamab duocarmazine continues to show promise in mCRPC
May 10th 2024Updated data from the phase 2 TAMARCK study continued to show safety and preliminary efficacy with the B7-H3–targeting antibody-drug conjugate vobramitamab duocarmazine in patients with metastatic castration-resistant prostate cancer.